{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:28:07Z","timestamp":1790771287297,"version":"4.1.0"},"reference-count":191,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015974","name":"Istituto di Ricerche Farmacologiche Mario Negri - IRCCS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015974","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.dld.2023.10.029","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T12:21:22Z","timestamp":1701174082000},"page":"223-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) \u2013 Part I \u2013 Surgical treatments"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0946-3859","authenticated-orcid":false,"given":"Giuseppe","family":"Cabibbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Borzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Casadei-Gardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Cillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Colli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Dadduzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dionisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Farinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Gardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Giovanni","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Golfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Minozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Piscaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Rimassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Romanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Vigan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Trevisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2023.10.029_bib0001","unstructured":"https:\/\/snlg.iss.it\/wp-content\/uploads\/2023\/02\/LG97_AISF-AIOM_Epatocarcinoma.pdf"},{"key":"10.1016\/j.dld.2023.10.029_bib0002","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0003","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0004","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/liv.14735","article-title":"The changing scenario of hepatocellular carcinoma in Italy: an update","volume":"41","author":"Garuti","year":"2021","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0005","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23485","article-title":"A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma","volume":"51","author":"Cabibbo","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0006","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hep.27443","article-title":"Prognosis of untreated hepatocellular carcinoma","volume":"61","author":"Giannini","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0007","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1478-3231.2009.01994.x","article-title":"Prognostic scores for hepatocellular carcinoma: none is the winner","volume":"29","author":"Camm\u00e0","year":"2009","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0008","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","article-title":"HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis","volume":"77","author":"Singal","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2023.10.029_bib0009","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1016\/S1470-2045(23)00186-9","article-title":"HCC Special Interest Group of the Italian Association for the Study of the Liver. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept","volume":"24","author":"Vitale","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2023.10.029_bib0010","series-title":"Manuale metodologico per la produzione di linee guida di pratica clinica","year":"2020"},{"key":"10.1016\/j.dld.2023.10.029_bib0011","series-title":"GRADEpro gdt [Computer program] mcmaster university (developed by evidence prime) GRADEpro gdt","year":"2021"},{"key":"10.1016\/j.dld.2023.10.029_bib0012","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2011"},{"key":"10.1016\/j.dld.2023.10.029_bib0013","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0014","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ncpgasthep1357","article-title":"Multimodal approaches to the treatment of hepatocellular carcinoma","volume":"6","author":"Cabibbo","year":"2009","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.dld.2022.01.122","article-title":"Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function","volume":"54","author":"Cabibbo","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0016","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0017","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jhep.2017.01.033","article-title":"Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma","volume":"67","author":"Cabibbo","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0040-1719178","article-title":"Role of multidisciplinary care in the management of hepatocellular carcinoma","volume":"41","author":"Byrd","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2023.10.029_bib0019","doi-asserted-by":"crossref","first-page":"e0143","DOI":"10.1097\/HC9.0000000000000143","article-title":"Multidisciplinary care for patients with HCC: a systematic review and meta-analysis","volume":"7","author":"Seif El Dahan","year":"2023","journal-title":"Hepatol Commun"},{"issue":"9","key":"10.1016\/j.dld.2023.10.029_bib0020","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/MCG.0000000000000825","article-title":"Multidisciplinary management of hepatocellular carcinoma improves access to therapy and patient survival","volume":"51","author":"Agarwal","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2023.10.029_bib0021","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.clinre.2018.11.005","article-title":"Impact of physician experience and multidisciplinary team on clinical outcome in patients receiving Sorafenib","volume":"43","author":"Casadei Gardini","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8","key":"10.1016\/j.dld.2023.10.029_bib0022","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jso.25738","article-title":"Optimizing cancer care for hepatocellular carcinoma at a safety-net hospital: the value of a multidisciplinary disease management team","volume":"120","author":"Duininck","year":"2019","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.dld.2023.10.029_bib0023","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S1665-2681(19)31318-3","article-title":"Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients","volume":"12","author":"Gaba","year":"2013","journal-title":"Ann Hepatol"},{"issue":"8","key":"10.1016\/j.dld.2023.10.029_bib0024","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/j.gastro.2017.02.040","article-title":"Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality","volume":"152","author":"Serper","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210730","article-title":"Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients","volume":"14","author":"Sinn","year":"2019","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0026","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1245\/s10434-013-3413-8","article-title":"Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome","volume":"21","author":"Yopp","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.dld.2023.10.029_bib0027","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0028","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.10.029_bib0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5009\/gnl19024","article-title":"2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma","volume":"13","year":"2019","journal-title":"Gut Liver"},{"key":"10.1016\/j.dld.2023.10.029_bib0030","first-page":"45","article-title":"Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2013 update (3rd JSH-HCC Guidelines)","author":"Kokudo","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2023.10.029_bib0031","unstructured":"Raccomandazioni Multisocietarie Italiane (AISF, AIOM, IT-IHPBA, SIC, SIRM, SITO) per la gestione clinica integrata del paziente con epatocarcinoma. https:\/\/www.webaisf.org\/wpcontent\/uploads\/2019\/02\/position_paper_hcc_v30_22.12.1.pdf"},{"issue":"2","key":"10.1016\/j.dld.2023.10.029_bib0032","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2016.09.012","article-title":"Personalized treatment of patients with very early hepatocellular carcinoma","volume":"66","author":"Vitale","year":"2017","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.dld.2023.10.029_bib0033","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.14309\/ajg.0000000000001256","article-title":"Effect of diameter and number of hepatocellular carcinomas on survival after resection, transarterial chemoembolization, and ablation","volume":"116","author":"Kawaguchi","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2023.10.029_bib0034","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hep.21933","article-title":"Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?","volume":"47","author":"Livraghi","year":"2008","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.dld.2023.10.029_bib0035","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/jgh.15440","article-title":"Evaluation of clinical outcomes of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: a systematic review and meta-analysis of recent randomized controlled trials","volume":"36","author":"Jia","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0036","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/SLA.0000000000004350","article-title":"Liver resection versus local ablation therapies for hepatocellular carcinoma within the Milan criteria: a systematic review and meta-analysis","volume":"273","author":"Shin","year":"2021","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0037","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000489836","article-title":"Open liver resection, laparoscopic liver resection, and percutaneous thermal ablation for patients with solitary small hepatocellular carcinoma (\u226430mm): review of the literature and proposal for a therapeutic strategy","volume":"35","author":"Vigan\u00f2","year":"2018","journal-title":"Dig Surg"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0038","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"Chen","year":"2006","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0039","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","article-title":"A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria","volume":"252","author":"Huang","year":"2010","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0040","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","article-title":"A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma","volume":"57","author":"Feng","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0041","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/jgh.12441","article-title":"Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma","volume":"29","author":"Fang","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.dld.2023.10.029_bib0042","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/bjs.10677","article-title":"Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma","volume":"104","author":"Ng","year":"2017","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.dld.2023.10.029_bib0043","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4174\/astr.2018.94.2.74","article-title":"A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma 2018","volume":"94","author":"Lee","year":"2018","journal-title":"Ann Surg Treat Res"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0044","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jhep.2018.02.026","article-title":"Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: propensity score analyses of long-term outcomes","volume":"69","author":"Lee","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0045","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.hpb.2017.12.001","article-title":"Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection","volume":"20","author":"Chong","year":"2018","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0046","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000497112","article-title":"Laparoscopic hepatectomy (with or without Robotic Assistance) versus radiofrequency ablation as a minimally invasive treatment for very early-stage or early-stage hepatocellular carcinoma","volume":"37","author":"Chong","year":"2020","journal-title":"Dig Surg"},{"issue":"12","key":"10.1016\/j.dld.2023.10.029_bib0047","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/liv.14258","article-title":"Surgical resection versus radiofrequency ablation very early-stage HCC (\u2264 2cm Single HCC): a propensity score analysis","volume":"39","author":"Chu","year":"2019","journal-title":"Liver Int"},{"issue":"18","key":"10.1016\/j.dld.2023.10.029_bib0048","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3748\/wjg.v27.i18.2205","article-title":"Radiofrequency ablation vs surgical resection in elderly patients with hepatocellular carcinoma in Milan criteria","volume":"27","author":"Conticchio","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.dld.2023.10.029_bib0049","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.ejso.2019.04.023","article-title":"Single Hepatocellular Carcinoma approached by curative-intent treatment: a propensity score analysis comparing radiofrequency ablation and liver resection","volume":"45","author":"Di Sandro","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.dld.2023.10.029_bib0050","first-page":"3489","article-title":"Laparoscopic liver resection is a feasible treatment for patients with hepatocellular carcinoma and portal hypertension","volume":"36","author":"Harada","year":"2016","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.dld.2023.10.029_bib0051","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/liv.13166","article-title":"Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis","volume":"36","author":"He","year":"2016","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0052","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/hepr.12592","article-title":"Outcomes of laparoscopic hepatic resection versus percutaneous radiofrequency ablation for hepatocellular carcinoma located at the liver surface: a case-control study with propensity score matching","volume":"46","author":"Ito","year":"2016","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0053","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/SLA.0000000000002751","article-title":"Treatment optimization for hepatocellular carcinoma in elderly patients in a japanese nationwide cohort","volume":"270","author":"Kaibori","year":"2019","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0054","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/bjs5.60","article-title":"Propensity score-matched comparison of non-anatomical resection and radiofrequency ablation for hepatocellular carcinoma in patients with up to three tumours, each measuring up to 3cm in diameter","volume":"2","author":"Kato","year":"2018","journal-title":"BJS Open"},{"issue":"26","key":"10.1016\/j.dld.2023.10.029_bib0055","doi-asserted-by":"crossref","first-page":"e16279","DOI":"10.1097\/MD.0000000000016279","article-title":"Comparison of 2 curative treatment options for very early hepatocellular carcinoma: efficacy, recurrence pattern, and retreatment","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0056","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12876-021-01995-z","article-title":"Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis","volume":"21","author":"Li","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0057","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/SLA.0000000000001178","article-title":"Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma \u2264 2cm in a propensity score model","volume":"263","author":"Liu","year":"2016","journal-title":"Ann Sur"},{"issue":"10","key":"10.1016\/j.dld.2023.10.029_bib0058","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/hpb.12446","article-title":"Surgical resection versus ablation for hepatocellular carcinoma \u2264 3 cm: a population-based analysis","volume":"17","author":"Miura","year":"2015","journal-title":"HPB"},{"issue":"4 Pt A","key":"10.1016\/j.dld.2023.10.029_bib0059","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ejso.2019.10.026","article-title":"Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: a real world single center study","volume":"46","author":"Pan","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2013.03.009","article-title":"Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma \u22643cm. Results of a multicenter Italian survey","volume":"59","author":"Pompili","year":"2013","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0061","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.surg.2019.05.007","article-title":"Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma \u22645 cm: a propensity score-matched analysis","volume":"166","author":"Ryu","year":"2019","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.dld.2023.10.029_bib0062","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1007\/s00464-015-4737-1","article-title":"Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas","volume":"30","author":"Song","year":"2016","journal-title":"Surg Endosc"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0063","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/liv.13670","article-title":"Impact of resection and ablation for single hypovascular hepatocellular carcinoma \u22642cm analysed with propensity score weighting","volume":"38","author":"Takayasu","year":"2018","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.dld.2023.10.029_bib0064","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2011.05.020","article-title":"Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early\/early-stage hepatocellular carcinoma","volume":"56","author":"Wang","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0065","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.26231","article-title":"Health care costs associated with hepatocellular carcinoma: a population-based study","volume":"58","author":"Thein","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2023.10.029_bib0066","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2013.04.009","article-title":"Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma","volume":"59","author":"Cucchetti","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2023.10.029_bib0067","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/SLA.0000000000003192","article-title":"Liver resection for multiple hepatocellular carcinomas: a japanese nationwide survey","volume":"272","author":"Fukami","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2023.10.029_bib0068","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.27745","article-title":"The role of hepatic resection in the treatment of hepatocellular cancer","volume":"62","author":"Roayaie","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.10.029_bib0069","first-page":"348","article-title":"Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions","volume":"32","author":"Bolondi","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2023.10.029_bib0070","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jgh.12452","article-title":"Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer Stage B subclassification by survival analysis","volume":"29","author":"Ha","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2023.10.029_bib0071","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/liv.13487","article-title":"New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization","volume":"37","author":"Kim","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2023.10.029_bib0072","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s11604-014-0358-1","article-title":"Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: subclassifying the intermediate stage (Barcelona Clinic Liver Cancer stage B)","volume":"32","author":"Yamakado","year":"2014","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.dld.2023.10.029_bib0073","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1159\/000439290","article-title":"Subclassification of BCLC B stage hepatocellular carcinoma and treatment strategies: proposal of modified Bolondi's subclassification (Kinki criteria)","volume":"33","author":"Kudo","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.dld.2023.10.029_bib0074","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","article-title":"Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma","volume":"134","author":"Ishizawa","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2023.10.029_bib0075","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations? An observational study of the HCC East-West study group","volume":"257","author":"Torzilli","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2023.10.029_bib0076","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jhep.2014.10.037","article-title":"Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study","volume":"62","author":"Vitale","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0077","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0078","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2014.03.012","article-title":"Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT","volume":"61","author":"Yin","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2023.10.029_bib0079","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SLA.0000000000000236","article-title":"Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma","volume":"260","author":"Zhong","year":"2014","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.dld.2023.10.029_bib0080","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/cas.13257","article-title":"Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: a multicenter study from Japan","volume":"108","author":"Tada","year":"2017","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0081","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/cam4.2038","article-title":"Liver resection versus transarterial chemoembolization for the treatment of intermediate- stage hepatocellular carcinoma","volume":"8","author":"Chen","year":"2019","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0082","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12876-020-01235-w","article-title":"Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis","volume":"20","author":"Lin","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0083","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.hpb.2019.08.016","article-title":"Is laparoscopic liver resection suitable for selected patients with BCLC stage B HCC? A propensity score-matched analysis","volume":"22","author":"Peng","year":"2020","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0084","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4174\/astr.2020.99.4.238","article-title":"Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria","volume":"99","author":"Oh","year":"2020","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.dld.2023.10.029_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.618937","article-title":"Hepatic resection versus transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a Cohort Study","volume":"11","author":"Lu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.dld.2023.10.029_bib0086","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1872-034X.2007.00119.x","article-title":"Report of the 17th nationwide follow-up survey of primary liver cancer in Japan","volume":"37","author":"Ikai","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2023.10.029_bib0087","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jhep.2016.05.044","article-title":"Liver Cancer Study Group of Japan. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion","volume":"65","author":"Kokudo","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2023.10.029_bib0088","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/hep.29668","article-title":"Italian Liver Cancer (ITA.LI.CA) group. Patients with advanced hepatocellular carcinoma need a personalized management: a lesson from clinical practice","volume":"67","author":"Giannini","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.10.029_bib0089","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejso.2017.11.022","article-title":"The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review","volume":"44","author":"Glantzounis","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.dld.2023.10.029_bib0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2014.04.032","article-title":"Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis","volume":"61","author":"Kokudo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2023.10.029_bib0091","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1245\/s10434-010-0940-4","article-title":"Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"17","author":"Shi","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.dld.2023.10.029_bib0092","doi-asserted-by":"crossref","first-page":"e13542","DOI":"10.1111\/eci.13542","article-title":"Pattern of macrovascular invasion in hepatocellular carcinoma","volume":"51","author":"Guarino","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2023.10.029_bib0093","doi-asserted-by":"crossref","first-page":"e3959","DOI":"10.1097\/MD.0000000000003959","article-title":"Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus","volume":"95","author":"Zheng","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.dld.2023.10.029_bib0094","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1097\/MD.0000000000003015","article-title":"Multimodality Treatment for Hepatocellular Carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.dld.2023.10.029_bib0095","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fonc.2020.00573","article-title":"Resection vs. sorafenib for hepatocellular carcinoma with macroscopic vascular invasion: a real world, propensity score matched analytic study","volume":"10","author":"Mei","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0096","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/SLA.0000000000005373","article-title":"Hepatectomy versus sorafenib in advanced nonmetastatic hepatocellular carcinoma: a real-life multicentric weighted comparison","volume":"275","author":"Famularo","year":"2022","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.dld.2023.10.029_bib0097","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000515554","article-title":"Comparison of surgical resection and systemic treatment for hepatocellular carcinoma with vascular invasion: national cancer database analysis","volume":"10","author":"Govalan","year":"2021","journal-title":"Liver Cancer"},{"issue":"5","key":"10.1016\/j.dld.2023.10.029_bib0098","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249426","article-title":"The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: a cohort study","volume":"16","author":"Ma\u00c3\u00e0hringer-Kunz","year":"2021","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0099","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.dld.2023.10.029_bib0100","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2023.10.029_bib0101","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.dld.2023.10.029_bib0102","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(09)60137-9","article-title":"Principles for allocation of scarce medical interventions","volume":"373","author":"Persad","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2023.10.029_bib0103","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/lt.24214","article-title":"Italian Liver Cancer Group Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: a multicenter cohort study using the alpha- fetoprotein model as a survival predictor","volume":"21","author":"Vitale","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2023.10.029_bib0104","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1245\/s10434-014-4099-2","article-title":"Survival benefit of liver transplantation versus resection for hepatocellular carcinoma: impact of MELD score","volume":"22","author":"Vitale","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.dld.2023.10.029_bib0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1600-6143.2009.02571.x","article-title":"Survival benefit-based deceased-donor liver allocation","volume":"9","author":"Schaubel","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2023.10.029_bib0106","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1600-6143.2011.03853.x","article-title":"Are patients with Child's A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation?","volume":"12","author":"Berry","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2023.10.029_bib0107","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.dld.2010.02.010","article-title":"The survival benefit of liver transplantation in hepatocellular carcinoma patients","volume":"42","author":"Cillo","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2023.10.029_bib0108","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1470-2045(11)70144-9","article-title":"Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study; Italian Liver Cancer group","volume":"12","author":"Vitale","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2023.10.029_bib0109","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.28998","article-title":"Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit","volume":"65","author":"Cillo","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.10.029_bib0110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jhep.2011.10.021","article-title":"Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines","volume":"56","author":"Takayasu","year":"2012","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.dld.2023.10.029_bib0111","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/cancers13102406","article-title":"Sustained complete response after biological downstaging in patients with hepatocellular carcinoma: XXL-Like prioritization for liver transplantation or \u201cWait and See\u201d Strategy?","volume":"13","author":"Vitale","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.dld.2023.10.029_bib0112","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1470-2045(20)30224-2","article-title":"Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b\/3 trial","volume":"21","author":"Mazzaferro","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0113","first-page":"910","article-title":"Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2023.10.029_bib0114","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jhep.2013.10.010","article-title":"A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list","volume":"60","author":"Vitale","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2023.10.029_bib0115","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1111\/ajt.13408","article-title":"A multistep, consensus-based approach to organ allocation in liver transplantation: toward a \u201cBlended Principle Model\u201d","volume":"15","author":"Cillo","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2023.10.029_bib0116","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/TP.0000000000003174","article-title":"Liver transplantation for hepatocellular carcinoma. Working Group Report from the ILTS transplant oncology consensus conference","volume":"104","author":"Mehta","year":"2020","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0117","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S2468-1253(20)30360-5","article-title":"Resuming liver transplantation amid the COVID-19 pandemic","volume":"6","author":"Thorburn","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0118","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1007\/s00268-015-2987-7","article-title":"The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma","volume":"39","author":"Spolverato","year":"2015","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0119","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria","volume":"61","author":"Kim","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.10.029_bib0120","article-title":"A taxonomy and framework for identifying and developing actionable statements in guidelines suggests avoiding informal recommendations","volume":"23","author":"Lofti","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2023.10.029_bib0121","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2016.07.006","article-title":"Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group","volume":"80","author":"Guyatt","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.dld.2023.10.029_bib0122","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.dld.2023.10.029_bib0123","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.dld.2013.01.012","article-title":"Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma","volume":"45","author":"Italian Association for the Study of the Liver (AISF)","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2023.10.029_bib0124","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","article-title":"Liver transplantation for hepatocellular carcinoma: validation of the UCSF- expanded criteria based on preoperative imaging","volume":"7","author":"Yao","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2023.10.029_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2023.10.029_bib0126","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.21445","article-title":"Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center","volume":"14","author":"Lee","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2023.10.029_bib0127","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/ctr.12534","article-title":"Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience","volume":"29","author":"Bonadio","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.dld.2023.10.029_bib0128","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","article-title":"Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria","volume":"143","author":"Duvoux","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0129","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2016.10.038","article-title":"Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC","volume":"66","author":"Notarpaolo","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2023.10.029_bib0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hep.27787","article-title":"Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: a prospective validation","volume":"62","author":"Toso","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0131","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","article-title":"Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma","volume":"154","author":"Mazzaferro","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2023.10.029_bib0132","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.sla.0000109146.72827.76","article-title":"Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma","volume":"239","author":"Cillo","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0133","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.28643","article-title":"The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: a prospective validation study","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"issue":"8\u201316","key":"10.1016\/j.dld.2023.10.029_bib0134","article-title":"Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria","volume":"209","author":"Li","year":"2017","journal-title":"J Surg Res"},{"issue":"5","key":"10.1016\/j.dld.2023.10.029_bib0135","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1245\/s10434-008-9851-z","article-title":"Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation","volume":"15","author":"Facciuto","year":"2008","journal-title":"Ann Surl Oncol"},{"issue":"1","key":"10.1016\/j.dld.2023.10.029_bib0136","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jso.21415","article-title":"Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma","volume":"101","author":"Lee","year":"2010","journal-title":"J Surg Oncol"},{"issue":"29","key":"10.1016\/j.dld.2023.10.029_bib0137","doi-asserted-by":"crossref","first-page":"47555","DOI":"10.18632\/oncotarget.17733","article-title":"Comparison of treatment outcome between living donor liver transplantation and Sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria","volume":"8","author":"Cho","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.dld.2023.10.029_bib0138","doi-asserted-by":"crossref","first-page":"515","DOI":"10.12659\/AOT.884018","article-title":"Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria - Is it time or a more individual approach?","volume":"18","author":"Heinzow","year":"2013","journal-title":"Ann Transplant"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0139","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.transproceed.2010.02.027","article-title":"Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?","volume":"42","author":"Kim","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.dld.2023.10.029_bib0140","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/SLA.0000000000004259","article-title":"Liver Resection for early hepatocellular carcinoma: preoperative predictors of non-transplantable recurrence and implications for treatment allocation","volume":"272","author":"Gelli","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2023.10.029_bib0141","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.29468","article-title":"Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: an intention-to-treat analysis","volume":"67","author":"de Haas","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0142","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/cancers13061416","article-title":"Liver transplantation for T2 hepatocellular carcinoma during the COVID-19 pandemic: a novel model balancing individual benefit against healthcare resources","volume":"13","author":"Cillo","year":"2021","journal-title":"Cancers"},{"issue":"48","key":"10.1016\/j.dld.2023.10.029_bib0143","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.3748\/wjg.v19.i48.9183","article-title":"Transplant benefit for patients with hepatocellular carcinoma","volume":"19","author":"Vitale","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.dld.2023.10.029_bib0144","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/liv.14154","article-title":"The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: a multicenter cohort study","volume":"39","author":"Vitale","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2023.10.029_bib0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/SLA.0000000000001442","article-title":"Salvage versus primary liver transplantation for early hepatocellular carcinoma: do both strategies yield similar outcomes?","volume":"264","author":"Bhangui","year":"2016","journal-title":"Ann Surg"},{"issue":"19","key":"10.1016\/j.dld.2023.10.029_bib0146","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3748\/wjg.v18.i19.2415","article-title":"Salvage liver transplantation in the treatment of hepatocellular carcinoma: a Meta-analysis","volume":"18","author":"Li","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.dld.2023.10.029_bib0147","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1097\/TP.0000000000001730","article-title":"Locoregional therapy with curative intent versus primary liver transplant for hepatocellular carcinoma: systematic review and meta-analysis","volume":"101","author":"Murali","year":"2017","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.dld.2023.10.029_bib0148","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1016\/j.transproceed.2016.09.047","article-title":"Harm and benefits of salvage transplantation for hepatocellular carcinoma: an updated meta-analysis","volume":"48","author":"Xiong","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.dld.2023.10.029_bib0149","doi-asserted-by":"crossref","first-page":"524","DOI":"10.12659\/AOT.908623","article-title":"Salvage liver transplant versus primary liver transplant for patients with hepatocellular carcinoma","volume":"23","author":"Yadav","year":"2018","journal-title":"Ann. Transplant."},{"issue":"9","key":"10.1016\/j.dld.2023.10.029_bib0150","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.transproceed.2013.06.004","article-title":"Short- and long-term outcomes after salvage liver transplantation versus primary liver transplantation for hepatocellular carcinoma: a meta-analysis","volume":"45","author":"Zhu","year":"2013","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0151","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/he.2000.5763","article-title":"Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome- oriented decision analysis","volume":"31","author":"Majno","year":"2000","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.dld.2023.10.029_bib0152","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00004836-200608000-00018","article-title":"Liver transplantation for hepatocellular carcinoma: a survey of practices","volume":"40","author":"Van Kleek","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0153","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.sla.0000090449.87109.44","article-title":"Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?","volume":"238","author":"Adam","year":"2003","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0154","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.sla.0000098621.74851.65","article-title":"Resection prior to liver transplantation for hepatocellular carcinoma","volume":"238","author":"Belghiti","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2023.10.029_bib0155","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1600-6143.2008.02229.x","article-title":"Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: university of Bologna experience","volume":"8","author":"Del Gaudio","year":"2008","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.dld.2023.10.029_bib0156","article-title":"Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.dld.2023.10.029_bib0157","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/lt.20398","article-title":"Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class a patients with cirrhosis who are eligible for liver transplantation","volume":"11","author":"Margarit","year":"2005","journal-title":"Liver Transplant."},{"issue":"9","key":"10.1016\/j.dld.2023.10.029_bib0158","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1007\/s00268-010-0583-4","article-title":"Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series","volume":"34","author":"Sapisochin","year":"2010","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0159","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.21431","article-title":"Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation","volume":"14","author":"Scatton","year":"2008","journal-title":"Liver Transplant."},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0160","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.transproceed.2007.05.073","article-title":"First-line liver resection and salvage transplantation are increasing therapeutics strategies for patients with hepatocellular carcinoma and child A cirrhosis","volume":"39","author":"Vennarecci","year":"2007","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.dld.2023.10.029_bib0161","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.dld.2012.01.018","article-title":"What is the probability of being too old for salvage transplantation after hepatocellular carcinoma resection?","volume":"44","author":"Cucchetti","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2023.10.029_bib0162","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/cancers12020452","article-title":"Identification of an upper limit of tumor burden for downstaging in candidates with hepatocellular cancer waiting for liver transplantation: a West\u2013East Collaborative Effort","volume":"12","author":"Lai","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.dld.2023.10.029_bib0163","first-page":"1185","article-title":"Are there upper limits in tumor burden for down-staging of hepatocellular carcinoma to liver transplant?","volume":"70","author":"Sinha","year":"2019","journal-title":"Anal. All-Comers Protocol Hepatol"},{"key":"10.1016\/j.dld.2023.10.029_bib0164","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/TP.0000000000001402","article-title":"Predictors of successful downstaging of hepatocellular carcinoma outside Milan criteria","volume":"100","author":"Murali","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2023.10.029_bib0165","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cgh.2017.11.037","article-title":"Excellent outcomes of Liver transplantation following down staging of hepatocellular carcinoma to within Milan criteria\u2014a multi-center study","volume":"16","author":"Mehta","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2023.10.029_bib0166","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1111\/ajt.13408","article-title":"I-BELT (Italian Board of Experts in the Field of Liver Transplantation). A multistep, consensus-based approach to organ allocation in liver transplantation: toward a \u201cBlended Principle Model\u201d","volume":"15","author":"Cillo","year":"2015","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.dld.2023.10.029_bib0167","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/liv.13755","article-title":"Specific issues concerning the management of patients on the waiting list and after liver transplantation","volume":"38","author":"Burra","year":"2018","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.dld.2023.10.029_bib0168","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/lt.20526","article-title":"A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation","volume":"11","author":"Yao","year":"2005","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0169","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.22412","article-title":"Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis","volume":"48","author":"Yao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.10.029_bib0170","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: longterm outcome compared to tumors within Milan criteria","volume":"61","author":"Yao","year":"2015","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.dld.2023.10.029_bib0171","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1600-6143.2008.02409.x","article-title":"Liver transplantation for hepatocellular carcinoma: results of down- staging in patients initially outside the Milan selection criteria","volume":"8","author":"Ravaioli","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2023.10.029_bib0172","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.30413","article-title":"Alpha-fetoprotein decrease from >1,000 to < 500ng\/mL in patients with hepatocellular carcinoma leads to improved posttransplant outcomes","volume":"69","author":"Mehta","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0173","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.30879","article-title":"National experience on down-staging of hepatocellular carcinoma before liver transplant: influence of tumor burden, alpha-fetoprotein, and wait time","volume":"71","author":"Mehta","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.10.029_bib0174","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s11605-013-2229-y","article-title":"Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria","volume":"17","author":"Lei","year":"2013","journal-title":"Gastrointest Surg"},{"issue":"9","key":"10.1016\/j.dld.2023.10.029_bib0175","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/bjs.7561","article-title":"Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria","volume":"98","author":"Gordon-Weeks","year":"2011","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0176","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jamcollsurg.2016.12.020","article-title":"Liver transplantation for advanced hepatocellular carcinoma after downstaging without up-front stage restrictions","volume":"224","author":"Chapman","year":"2017","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.dld.2023.10.029_bib0177","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00270-012-0458-1","article-title":"Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies","volume":"36","author":"Bova","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.dld.2023.10.029_bib0178","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/tri.13337","article-title":"Downstaging prior to liver transplantation for hepatocellular carcinoma: advisable but at the price of an increased risk of cancer recurrence \u2013 a retrospective study","volume":"32","author":"Toso","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.dld.2023.10.029_bib0179","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/lt.20837","article-title":"Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma","volume":"12","author":"Otto","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2023.10.029_bib0180","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/liv.12966","article-title":"Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy","volume":"36","author":"Finkenstedt","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2023.10.029_bib0181","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00268-016-3682-z","article-title":"Yttrium -90 radioembolization for hepatocellular carcinoma prior to liver transplantation","volume":"41","author":"Ettorre","year":"2017","journal-title":"World J Surg"},{"issue":"Suppl 2","key":"10.1016\/j.dld.2023.10.029_bib0182","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/lt.22365","article-title":"Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience","volume":"17","author":"Mazzaferro","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2023.10.029_bib0183","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1159\/000507887","article-title":"The real impact of bridging or downstaging on survival outcomes after liver transplantation for hepatocellular carcinoma","volume":"9","author":"Lee","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.dld.2023.10.029_bib0184","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41598-019-40543-4","article-title":"Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria","volume":"9","author":"Ravaioli","year":"2019","journal-title":"Sci Rep"},{"issue":"10415","key":"10.1016\/j.dld.2023.10.029_bib0185","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial","volume":"402","author":"Qin","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.dld.2023.10.029_bib0186","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.07.040","article-title":"Direct-acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinoma","volume":"157","author":"Singal","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2023.10.029_bib0187","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2019.03.027","article-title":"Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients","volume":"71","author":"Cabibbo","year":"2019","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2023.10.029_bib0188","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jhep.2021.01.046","article-title":"Antiviral therapy in the palliative setting of HCC (BCLC-B and -C)","volume":"74","author":"Reig","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2023.10.029_bib0189","article-title":"Indolent cancer and pattern of progression: two missing parameters in trial design for hepatology","author":"Iavarone","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.dld.2023.10.029_bib0190","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.seminoncol.2012.05.006","article-title":"Causes of and prevention strategies for hepatocellular carcinoma","volume":"39","author":"Cabibbo","year":"2012","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.dld.2023.10.029_bib0191","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/liv.13242","article-title":"Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma","volume":"37","author":"Pecorelli","year":"2017","journal-title":"Liver Int"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823010198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823010198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:23:29Z","timestamp":1761625409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865823010198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":191,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1590865823010198"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2023.10.029","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) \u2013 Part I \u2013 Surgical treatments","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2023.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}